Home » Stocks » OMCL

Omnicell, Inc. (OMCL)

Stock Price: $146.50 USD 4.66 (3.29%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
Market Cap 6.26B
Revenue (ttm) 914.37M
Net Income (ttm) 35.01M
Shares Out 42.96M
EPS (ttm) 1.32
PE Ratio 110.65
Forward PE 42.74
Dividend n/a
Dividend Yield n/a
Trading Day July 30
Last Price $146.50
Previous Close $141.84
Change ($) 4.66
Change (%) 3.29%
Day's Open 142.58
Day's Range 140.58 - 147.33
Day's Volume 307,872
52-Week Range 66.04 - 154.92

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Omnicell (OMCL) reports better-than-expected revenues on strong segmental performance driving the top line in second-quarter 2021.

11 hours ago - Zacks Investment Research

Omnicell Inc (NASDAQ: OMCL) reported second-quarter FY21 revenue growth of 36.6% year-on-year to $272.7 million, beating the analyst consensus of $268.5 million. The increase in revenues reflects moment...

1 day ago - Benzinga

Omnicell (OMCL) delivered earnings and revenue surprises of 21.25% and 2.07%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 day ago - Zacks Investment Research

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Spartanburg Regional Healthcare System Partners with Omnicell to Drive Improved Clinical and Operational Outcomes

1 day ago - Business Wire

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced res...

1 day ago - Business Wire

Omnicell's (OMCL) second-quarter 2021 guidance includes additional freight costs, given the ongoing global market conditions.

4 days ago - Zacks Investment Research

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Acquire FDS Amplicare

4 days ago - Business Wire

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Appoints Edward Bousa to Board of Directors

2 weeks ago - Business Wire

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Release Second Quarter 2021 Financial Results on July 29, 2021

2 weeks ago - Business Wire

Omnicell (OMCL) and Chartwell partner to implement Omnicell's IVX Workflow for the management of chemotherapy drug product preparations.

3 weeks ago - Zacks Investment Research

CPSI vs. OMCL: Which Stock Is the Better Value Option?

Other stocks mentioned: CPSI
3 weeks ago - Zacks Investment Research

PITTSBURGH--(BUSINESS WIRE)--Chartwell Enhances IV Preparations with Omnicell® IVX Workflow

3 weeks ago - Business Wire

Within the last quarter, Omnicell (NASDAQ:OMCL) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 1 1 0 Somewhat Bullish 1 0 1 0 Indifferent 0 1 0 ...

1 month ago - Benzinga

With the trading day about halfway over, the markets were trading sideways yet again, and it seems like the major averages may be stuck on this plateau.

Other stocks mentioned: RIDE, RMD, CKPT, HLX, HMPT, MS, REGI ...
1 month ago - 24/7 Wall Street

CPSI vs. OMCL: Which Stock Is the Better Value Option?

Other stocks mentioned: CPSI
1 month ago - Zacks Investment Research

NXGN vs. OMCL: Which Stock Is the Better Value Option?

Other stocks mentioned: NXGN
2 months ago - Zacks Investment Research

Omnicell's (OMCL) raises adjusted EPS guidance for 2021 , which buoys optimism.

3 months ago - Zacks Investment Research

Omnicell (OMCL) delivered earnings and revenue surprises of 23.88% and 2.65%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of Omnicell (NASDAQ:OMCL) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 25.76% over the past year to $0.83, which beat th...

3 months ago - Benzinga

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Sc...

3 months ago - Business Wire

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Announces Financial Results for First Quarter 2021

3 months ago - Business Wire

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--EnlivenHealth Partners with Twilio to Accelerate Launch of Transformative Patient Communications Solutions

3 months ago - Business Wire

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Putting progress ahead of politics is just one lesson Omnicell CEO Lipps picked up while building the leader in a key corner of the health care business. The post Why Omnicell's CEO Puts Progress Over P...

3 months ago - Investors Business Daily

Investors are optimistic about Omnicell (OMCL) owing to its progress with its three-legged strategic, which is driving growth and an impressive 2025 roadmap.

3 months ago - Zacks Investment Research

Omnicell's (OMCL) Autonomous Pharmacy vision receives another boost with the latest service adoption by Aultman.

3 months ago - Zacks Investment Research

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aultman Health Foundation to Enhance Medication Management with Omnicell's Central Pharmacy Dispensing Service

3 months ago - Business Wire

Omnicell (OMCL) expands its autonomous pharmacy portfolio with the acquisition of PSG's 340B Link business.

3 months ago - Zacks Investment Research

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Release First Quarter 2021 Financial Results on April 29, 2021

3 months ago - Business Wire

Omnicell (OMCL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t...

4 months ago - Zacks Investment Research

Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock?

4 months ago - Zacks Investment Research

Omnicell (OMCL) is progressing in autonomous pharmacy space by expanding portfolio and investing in the digital cloud-based platform.

4 months ago - Zacks Investment Research

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Appoints Christine Mellon as Chief People Officer

5 months ago - Business Wire

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Present at Upcoming Investor Conferences

5 months ago - Business Wire

Omnicell saw its IBD SmartSelect Composite Rating jump to 96 Friday, up from 94 the day before. The post Omnicell Sees Composite Rating Move Up To 96 appeared first on Investor's Business Daily.

5 months ago - Investors Business Daily

Omnicell's (OMCL) fourth-quarter 2020 revenues rose 0.36% year over year to $249.2 million, improving 16.1% sequentially.

5 months ago - Zacks Investment Research

Omnicell, Inc. (OMCL) CEO Randall Lipps on Q4 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Shares of Omnicell (NASDAQ:OMCL) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 18.18% year over year to $0.91, which beat the esti...

5 months ago - Benzinga

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Reports Fiscal Year, Fourth Quarter 2020 Results Record 2020 Total Product Bookings of $1+ billion Full Year 2020 Revenues of $892.2 million

5 months ago - Business Wire

Omnicell (NASDAQ:OMCL) releases its next round of earnings this Monday, February 01. Get the latest predictions in Benzinga's essential guide to the company's Q4 earnings report.

6 months ago - Benzinga

3 Top Medical Info Systems Stocks to Beat COVID-19 Resurgence Crisis

Other stocks mentioned: NH, NXGN
6 months ago - Zacks Investment Research

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--WVU Medicine Selects Omnicell One Intelligence Solution to Drive Better Pharmacy Inventory Management, Optimize Costs, Support Better Patient Care

6 months ago - Business Wire

Omnicell (OMCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

Per the preliminary announcement, Omnicell (OMCL) projects 2020 total revenues to surpass its previous guidance.

6 months ago - Zacks Investment Research

Omnicell (OMCL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

6 months ago - Zacks Investment Research

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Announces Preliminary Fiscal Year 2020 Financial Results

6 months ago - Business Wire

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell's EnlivenHealth™ Reports Strong Customer Demand for New SaaS Technology Solution to Help Pharmacies Meet COVID-19 Vaccination Challenges

6 months ago - Business Wire

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Partner with Guy's and St Thomas' NHS Foundation Trust, London on Development of European Technology-Enabled Intelligence Centre

6 months ago - Business Wire

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Owensboro Health to Deploy Omnicell's Technology-Enabled Services to Improve Safety and Efficiency in Medication Management

7 months ago - Business Wire

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides p... [Read more...]

Industry
Health Information Services
IPO Date
Aug 7, 2001
CEO
Randall Lipps
Employees
2,970
Stock Exchange
NASDAQ
Ticker Symbol
OMCL
Full Company Profile

Financial Performance

In 2020, Omnicell's revenue was $892.21 million, a decrease of -0.54% compared to the previous year's $897.03 million. Earnings were $32.19 million, a decrease of -47.51%.

Financial Statements

Analyst Forecasts

According to 8 analysts, the average rating for Omnicell stock is "Buy." The 12-month stock price forecast is 156.67, which is an increase of 6.94% from the latest price.

Price Target
$156.67
(6.94% upside)
Analyst Consensus: Buy